Details for 2012196502
Up to date per 02.04.2026
Actions
Details for 2012196502
Granted/Registered
European Patent
18.09.2013 A
31.08.2016 B1
07.12.2007
US
12181 P
30.10.2008
US
109573 P
C07D 213/73 20060101AFI20130809BHEP
Owner
Vertex Pharmaceuticals Incorporated50 Northern Avenue Boston, MA 02210US
Representative
Representative
Gibler & Poth Patentanwälte KGDorotheergasse 7/141010 WienAT
Inventor
Siesel, David11145 Papoose Ct. San Diego, CA California 92127US
Information about Fees